VLKIM
VIVO

Van Lanschot Kempen Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,333,091
Closed -$40.6M – 225
2022
Q2 		$40.6M Sell
1,333,091
-211,163
-14% -$5.71M 1.46% 21
2022
Q1 		$40.1M Buy
1,544,254
+174,907
+13% +$4.16M 1.22% 25
2021
Q4 		$27.9M Buy
1,369,347
+818,144
+148% +$15.7M 0.86% 36
2021
Q3 		$10.6M Buy
551,203
+136,880
+33% +$2.73M 0.38% 86
2021
Q2 		$9.19M Buy
+414,323
New +$8.79M 0.33% 89

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Van Lanschot Kempen Investment Management's VIVO Position: Q3 2022 in Review

Van Lanschot Kempen Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 1,333,091 shares — an estimated $40.6M sold.

Van Lanschot Kempen Investment Management first reported a position in VIVO in Q2 2021 and held it in 5 quarters. The position peaked at $40.6M in Q2 2022. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Van Lanschot Kempen Investment Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Van Lanschot Kempen Investment Management sold 1,333,091 Meridian Bioscience Inc shares in Q3 2022, an estimated $40.6M.
  • Van Lanschot Kempen Investment Management first reported a position in Meridian Bioscience Inc in Q2 2021 and held it in 5 quarters.
  • Van Lanschot Kempen Investment Management's Meridian Bioscience Inc position peaked at $40.6M in Q2 2022.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.